When targeting GITR, murine Tregs were reprogrammed into CD4+ Th1 cells capable of producing IFN-γ and engaging in cytotoxic activity against GBM cells (Amoozgar et al., 2021). The gene discussed is CD4; the disease is glioblastoma.